相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
M-L Schubert et al.
ANNALS OF ONCOLOGY (2021)
Ruxolitinib mitigates steroid-refractory CRS during CAR T therapy
Jing Pan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
Hanren Dai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Adjuvant ruxolitinib therapy relieves steroid-refractory cytokine-release syndrome without impairing chimeric antigen receptor-modified T-cell function
Shuning Wei et al.
IMMUNOTHERAPY (2020)
Macrophage, the potential key mediator in CAR-T related CRS
Zhaonian Hao et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
Elizabeth L. Siegler et al.
FRONTIERS IN IMMUNOLOGY (2020)
T-memory cells against cancer: Remembering the enemy
Irene Sarkar et al.
CELLULAR IMMUNOLOGY (2019)
Management of T-Cell Engaging Immunotherapy Complications
Indumathy Varadarajan et al.
CANCER JOURNAL (2019)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease
Elina Zuelgaray et al.
ANNALS OF INTERNAL MEDICINE (2017)
The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model
Woldeab B. Haile et al.
NEUROBIOLOGY OF DISEASE (2016)
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
David T. Teachey et al.
CANCER DISCOVERY (2016)
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
Hanren Dai et al.
ONCOIMMUNOLOGY (2015)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers
Jack G. Shi et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
JAK-STAT signaling: From interferons to cytokines
Christian Schindler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
分享论文
